OANDA, GAIN Capital clash over API source code production

As the patent infringement lawsuit brought by OANDA against GAIN Capital, which is now owned by StoneX, continues at the New Jersey District Court, the parties have updated the Court on how the discovery process progresses.

According to a joint status report submitted at the Court on December 1, 2021 and seen by FX News Group, the parties request the Court’s assistance in resolving a dispute that has arisen with respect to the production of GAIN’s source code.

First, let’s recall that in this action, OANDA alleges that GAIN infringes two patents, U.S. Patent Nos. 7,146,336 (“the ’366 patent”) and 8,392,311 (“the ’311 patent”).

On March 5, 2013, the United States Patent and Trademark Office issued United States Patent No. 8,392,311, entitled “Currency Trading System, Methods, and Software.” The ’311 Patent teaches, among other things:

In one aspect, the present invention comprises a system for trading currencies over a computer network. A preferred embodiment comprises: (a) a server front-end; (b) at least one database; (c) a transaction server; (d) a rate server; (e) a pricing engine; (f) an interest rate manager; (g) a trade manager; (h) a value at risk server; (i) a margin control manager; (j) a trading system monitor; and (k) a hedging engine. In another aspect, the present invention comprises methods for trading currency over a computer network. In another aspect, the present invention comprises software for currency trading over a computer network.

On December 5, 2006, the United States Patent and Trademark Office duly and legally issued United States Patent No. 7,146,336, entitled “Currency Trading System, Methods, and Software.”

The ʼ336 Patent teaches, among other things:

In one aspect, the present invention comprises a system for trading currencies over a computer network. A preferred embodiment comprises: (a) a server front-end; (b) at least one database; (c) a transaction server; (d) a rate server; (e) a pricing engine; (f) an interest rate manager; (g) a trade manager; (h) a value at risk server; (i) a margin control manager; (j) a trading system monitor; and (k) a hedging engine. In another aspect, the present invention comprises methods for trading currency over a computer network. In another aspect, the present invention comprises software for currency trading over a computer network.

The latest status report informs the Court that, while the parties have met and conferred about the production of source code related to GAIN’s accused infringing product and OANDA has obtained some initial access to source code, GAIN has refused to provide access to its source code for the Application Programming Interfaces (APIs) used to operate GAIN’s automated trading platforms.

OANDA claims that the API portion of GAIN’s Forex.com source code is highly relevant because OANDA intends to use it to demonstrate to the jury how GAIN’s infringing Forex.com product works – e.g., by accepting client input and orders, transmitting those orders to the server via the APIs, and executing those orders on the servers.

OANDA argues that GAIN has provided no valid basis on which to withhold this discovery. Hence, OANDA requests that the Court order GAIN to provide prompt access to the API source code for both GAIN’s publicly documented as well as any private or non-advertised APIs.

GAIN Capital, however, requests that the Court strikes Plaintiff OANDA Corporation’s Request for Production that wrongfully encompasses a demand for production of GAIN’s “API handler” source code.

GAIN says that the “API handler” is a term used by OANDA’s counsel that refers to the back-end source code that “handles” or interprets commands and requests made by third parties. These third-party commands and requests can be made by using GAIN’s public application programming interface (API).

The API handler source code sought by OANDA is the source code that in essence interprets and translates the API requests and commands so that GAIN’s systems can understand and respond to them. It is not the source code for the GAIN trading platforms (which has already been produced).

OANDA’s Request should be stricken because OANDA fails to have any basis to support such Request, GAIN concludes.

Posted on

363 Replies to “OANDA, GAIN Capital clash over API source code production”

  4. where can i buy omifin Similarly, in patients with type II diabetes and hypertension, ambulatory BP monitoring indicated that unlike celecoxib and the nonselective NSAID comparator naproxen, rofecoxib led to significant increases in 24 h systolic BP, although all three drugs induced some destabilization of BP control 57

  14. Read information now. Learn about the side effects, dosages, and interactions.
    ivermectin price usa
    Drugs information sheet. Everything what you want to know about pills.

  15. Generic Name. Everything information about medication.
    https://stromectolst.com/# buy ivermectin for humans uk
    Learn about the side effects, dosages, and interactions. Everything about medicine.

  16. Everything information about medication. Medscape Drugs & Diseases.
    buy ivermectin cream
    Some trends of drugs. Everything what you want to know about pills.

  19. Prescription Drug Information, Interactions & Side. Best and news about drug.
    https://stromectolst.com/# cost of ivermectin
    Some trends of drugs. Prescription Drug Information, Interactions & Side.

  23. Definitive journal of drugs and therapeutics. Get information now.
    buy ivermectin uk
    Top 100 Searched Drugs. Comprehensive side effect and adverse reaction information.

  24. Definitive journal of drugs and therapeutics. Read information now.
    https://stromectolst.com/# ivermectin 1 cream 45gm
    п»їMedicament prescribing information. Drugs information sheet.

  28. Actual trends of drug. Definitive journal of drugs and therapeutics.
    https://stromectolst.com/# stromectol over the counter
    Everything what you want to know about pills. Commonly Used Drugs Charts.

  32. Drugs information sheet. What side effects can this medication cause?
    lisinopril 12.5 mg
    Everything what you want to know about pills. Everything about medicine.

  41. Get here. п»їMedicament prescribing information.
    https://levaquin.science/# generic levaquin without prescription
    drug information and news for professionals and consumers. Learn about the side effects, dosages, and interactions.

  42. Learn about the side effects, dosages, and interactions. Drugs information sheet.
    https://nexium.top/# where buy cheap nexium online
    Medscape Drugs & Diseases. Top 100 Searched Drugs.

  47. Definitive journal of drugs and therapeutics. Definitive journal of drugs and therapeutics.
    https://azithromycins.com/ zithromax 500 mg lowest price online
    Get here. safe and effective drugs are available.

  54. All trends of medicament. Read information now. amoxicillin 500 mg cost
    Definitive journal of drugs and therapeutics. Some are medicines that help people when doctors prescribe.

  58. Some are medicines that help people when doctors prescribe. Prescription Drug Information, Interactions & Side.
    https://finasteridest.online can i order propecia pills
    Actual trends of drug. Get information now.

  60. Get information now. Some are medicines that help people when doctors prescribe.
    best ed medications
    Some trends of drugs. drug information and news for professionals and consumers.

  62. Actual trends of drug. Comprehensive side effect and adverse reaction information.
    natural remedies for ed
    Everything information about medication. What side effects can this medication cause?

  63. Actual trends of drug. Medscape Drugs & Diseases.
    drugs for ed
    What side effects can this medication cause? Drug information.

  64. Comprehensive side effect and adverse reaction information. Definitive journal of drugs and therapeutics. where to buy amoxicillin
    Read information now. Drugs information sheet.

  66. Top 100 Searched Drugs. п»їMedicament prescribing information.
    ed treatments
    п»їMedicament prescribing information. Commonly Used Drugs Charts.

  67. Actual trends of drug. Read here.
    ed treatment review
    Definitive journal of drugs and therapeutics. drug information and news for professionals and consumers.

  68. All trends of medicament. safe and effective drugs are available.
    impotence pills
    All trends of medicament. Everything about medicine.

  69. Everything information about medication. Best and news about drug.
    https://edonlinefast.com erection pills that work
    drug information and news for professionals and consumers. Read now.

  73. drug information and news for professionals and consumers. drug information and news for professionals and consumers.
    canadapharmacyonline com
    п»їMedicament prescribing information. Cautions.

  74. Everything about medicine. Everything about medicine.
    canadian pharmacy 365
    What side effects can this medication cause? What side effects can this medication cause?

  86. Drug information. Top 100 Searched Drugs.
    sildenafil pill cost
    Some are medicines that help people when doctors prescribe. safe and effective drugs are available.

  101. Everything information about medication. Drug information.
    buy tadalafil uk
    All trends of medicament. Everything information about medication.

  190. best ed treatment pills [url=https://edpills.pro/#]top rated ed pills[/url] buy ed pills online

  193. high street discount pharmacy [url=http://pillswithoutprescription.pro/#]online canadian discount pharmacy[/url] best canadian mail order pharmacy

  278. how to buy cialis The organization of preoptic medullary circuits in the male rat evidence for interconnectivity of neural structures involved in reproductive behavior, antinociception and cardiovascular regulation

  361. 1995, 80 1357 1360 cialis coupons PKD is an autosomal dominant trait in Persian cats and Bull Terriers and is a suspected autosomal recessive trait in Cairn Terriers and West Highland White Terriers

Leave a Reply

Your email address will not be published. Required fields are marked *